For the Quarter Ending September 2023



North America

During the third quarter of the year, Naproxen prices in North America, particularly in the United States, experienced a notable decrease overall. While the first and second halves of the quarter saw minimal fluctuations, July 2023 marked a stable increase in Naproxen prices. This upward trend was driven by a consistent rise in demand from downstream pharmaceutical retailers and healthcare industries, prompting merchants to adjust their quotations accordingly. However, as the third quarter progressed, prices abruptly dropped, leading to increased inventories among domestic merchants. This sudden decline was attributed to heightened competition from generic manufacturers, as Naproxen is now off-patent, allowing various companies to produce and sell it. The influx of new generic drug manufacturers has intensified competition, resulting in lower prices. Additionally, changes in manufacturing costs and supply chain disruptions contributed to the fluctuating prices throughout the quarter. Despite these challenges, prices began to rebound steadily in September, indicating a balanced supply-demand scenario within the region.

Asia Pacific

Following a similar trend from the previous month, Naproxen prices in the Asia Pacific (APAC) region, especially in China, witnessed a consistent rise in the first half of the third quarter. Despite concerns related to the cautious stance on interest rate hikes by the US and European Federal Reserve, the National Bureau of Statistics reported a PMI of 49.3 in July, slightly higher than the previous month. This, coupled with increased purchasing activity from importing nations, led to higher quotations and a sustained rise in production momentum. However, as August approached, Naproxen prices in the APAC region experienced a determined decline, reflecting a pessimistic market outlook. The drop was influenced by a significant decrease in trade momentum, attributed to a sudden drop in purchasing activity and international quotations. Moving into September, prices rebounded moderately within the expected timeframe, balancing with available inventories among merchants. On the supply side, upstream markets showed sufficient accessibility, with higher export orders among traders at ports.

Get Real Time Prices of Naproxen: https://www.chemanalyst.com/Pricing-data/naproxen-1370

Europe

In line with the trend observed in the United States, Naproxen prices across the European market, particularly in Germany, witnessed a significant decrease throughout the third quarter of 2023. Consumption remained robust in July, maintaining a balanced market activity. However, as the quarter progressed, prices experienced a substantial drop in the German market. This decline was primarily due to reduced consumption from the end-user sector, especially in healthcare and pharmaceuticals. The European economy faced challenges such as persistent inflation, rising interest rates, and declining demand amid a global economic slowdown. This was evident in the notable decline in business confidence. Despite a lower headline inflation rate in Germany for August, analysts predicted an acceleration in the coming months. The German logistics market also suffered from a sharp decline in demand for warehouse and logistics space, contributing to overall negative market sentiments. Supply chain disruptions and a depreciating Euro against the US dollar further impacted the European economy, leading to decreased imports for the second consecutive month. Consequently, Naproxen prices in Europe continued to reflect a pessimistic market outlook until the end of September 2023.